1. IVERIC Bio. IZERVAY™ (avacincaptad pegol intravitreal solution): US prescribing information. 2023. https://ivericbio.com. Accessed 12 Sep 2023.
2. Jaffe GJ, Westby K, Csaky KG, et al. C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2/3 trial. Ophthalmology. 2021;128(4):576–86.
3. IVERIC Bio. Iveric Bio receives U.S. FDA approval for IZERVAY™ (avacincaptad pegol intravitreal solution), a new treatment for geographic atrophy [media release]. 5 Aug 2023. https://www.astellas.com/en/news/28281.
4. IVERIC Bio. Our science. 2023. https://ivericbio.com/our-science. Accessed 12 Sep 2023.
5. Ophthotech Corporation. Ophthotech raises $36 million; in-licenses two compounds for macular degeneration [media release]. 21 Feb 2008. https://www.fiercebiotech.com/biotech/press-release-ophthotech-raises-36-million-licenses-two-compounds-for-macular-degeneration.